Skip to main content
. 2012 Oct 30;11:134. doi: 10.1186/1475-2840-11-134

Figure 2.

Figure 2

Participant disposition. AML, amlodipine besylate; HCTZ, hydrochlorothiazide; OM, olmesartan medoxomil.